Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![amit_gupta444 Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1198165564750852096.png) Amit Gupta [@amit_gupta444](/creator/twitter/amit_gupta444) on x 1136 followers
Created: 2025-07-17 02:46:12 UTC

Lupin: The company announced the launch of Loteprednol Etabonate Ophthalmic Suspension, 0.5%, in the US. It is indicated for the treatment of steroid responsive inflammatory conditions. The drug had estimated annual sales of $XX million in the US.


XX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1945676380315746525/c:line.svg)

**Related Topics**
[amit](/topic/amit)

[Post Link](https://x.com/amit_gupta444/status/1945676380315746525)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

amit_gupta444 Avatar Amit Gupta @amit_gupta444 on x 1136 followers Created: 2025-07-17 02:46:12 UTC

Lupin: The company announced the launch of Loteprednol Etabonate Ophthalmic Suspension, 0.5%, in the US. It is indicated for the treatment of steroid responsive inflammatory conditions. The drug had estimated annual sales of $XX million in the US.

XX engagements

Engagements Line Chart

Related Topics amit

Post Link

post/tweet::1945676380315746525
/post/tweet::1945676380315746525